ஆராய்ச்சி நிறுவனம் ஆஃப் வெப்பமண்டல மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆராய்ச்சி நிறுவனம் ஆஃப் வெப்பமண்டல மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆராய்ச்சி நிறுவனம் ஆஃப் வெப்பமண்டல மருந்து Today - Breaking & Trending Today

DOT calls for cheaper COVID tests to encourage Pinoys to travel


Published July 16, 2021, 10:59 AM
Department of Tourism (DOT) Secretary Bernadette Romulo-Puyat on Friday, July 16 urged health facilities to lower the cost of their swab tests to encourage more people to travel and hasten the recovery of the tourism industry from the coronavirus disease (COVID-19) pandemic.
(Jansen Romero/ File photo/ MANILA BULLETIN)
Puyat said a cheaper option will lead to more domestic trips without sacrificing the test-before-travel requirement of most local government units (LGUs) as COVID-19 testing remains “expensive and out-of-reach” for budget-conscious travelers.
“The added cost of COVID-19 tests can be quite significant especially for big families traveling together. A slash in the cost of RT-PCR tests would encourage more travelers to pursue their travel plans,” Puyat explained. ....

Department Of Tourism , Research Institute Of Tropical Medicine , Philippine Children Medical Center , Secretary Bernadette Romulo Puyat , Reverse Transcription Polymerase Chain Reaction , Tourism Promotions Board , Philippine Children , Medical Center , Philippine General Hospital , Research Institute , Tropical Medicine , துறை ஆஃப் சுற்றுலா , ஆராய்ச்சி நிறுவனம் ஆஃப் வெப்பமண்டல மருந்து , பிலிப்பைன் குழந்தைகள் மருத்துவ மையம் , சுற்றுலா ப்ரமோஶந்ஸ் பலகை , பிலிப்பைன் குழந்தைகள் , மருத்துவ மையம் , பிலிப்பைன் ஜநரல் மருத்துவமனை , ஆராய்ச்சி நிறுவனம் , வெப்பமண்டல மருந்து ,

DOST approves 6 R&D projects as part of VIP program – DOST chief – Manila Bulletin


DOST Secretary Fortunato “Boy” T. de la Peña (PCOO/Manila Bulletin File photo)
DOST Secretary Fortunato T. de la Peña announced Friday, May 28, that the agency “has approved for implementation” the new R&D projects of the DOST-Industrial Technology Development Institute (ITDI) as part of the VIP program.
These are the following:
-Combination Therapy: Lytic Bacteriophages and Plant Extracts against Multidrug-Resistant Bacteria;
-Detection of Food and Water-borne Bacterial Pathogens using Phage-based Diagnostics;
-De novo synthesis of a non-Infective Zika Pseudovirus as reference for diagnostics and vaccines development;
-Development of Antibody Test Kits for COVID-19 using Enzyme Immunoassay; and ....

De La Pe , Philippines General , Annabelle Briones , Maria Terresea Dimamay , Vlps Pseudoviruses , Catherine Masangkay , Zika Pseudovirus , Gelito Joseph Sikat , Ursela Bigol , Luke Medical Center , Research Institute Of Tropical Medicine , Technology Development Institute , Development Of Antibody Test Kits , Department Of Science , Vaccine Development , Technology Institute Of The Philippines , Biotechnology Division , Virology Science , Technology Institute , Industrial Technology Development Institute , Philippine Common Viruses , Medical Importance , Pandemic Potential , Antigen Antibody Studies , Combination Therapy , Lytic Bacteriophages ,